Specialty Diagnostics — Segment assets

Business Segments · Segment assets

Thermo Fisher Scientific Specialty Diagnostics — Segment assets increased by 1.2% to $1.32B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.22B to $1.32B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
Rolls up toTotal Assets

How to read this metric

An increase may indicate capital expansion or investment in growth, while a decrease could signal asset divestment or improved capital efficiency.

Detailed definition

This metric represents the total book value of assets specifically allocated to the Specialty Diagnostics operating segm...

Peer comparison

Comparable to segment-specific asset bases reported by life science and diagnostic peers like Danaher or Abbott Laboratories.

Metric ID: tmo_segment_specialty_diagnostics_segment_assets

Historical Data

5 periods
 Q4 '23Q3 '24Q4 '24Q3 '25Q4 '25
Value$1.15B$1.23B$1.22B$1.31B$1.32B
QoQ Change+7.3%-1.3%+7.3%+1.2%
YoY Change+5.9%+5.9%+8.6%
Range$1.15B$1.32B
CAGR+15.0%
Avg YoY Growth+6.8%
Median YoY Growth+5.9%
Current Streak2 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's specialty diagnostics — segment assets?
Thermo Fisher Scientific (TMO) reported specialty diagnostics — segment assets of $1.32B in Q4 2025.
How has Thermo Fisher Scientific's specialty diagnostics — segment assets changed year-over-year?
Thermo Fisher Scientific's specialty diagnostics — segment assets increased by 8.6% year-over-year, from $1.22B to $1.32B.
What does specialty diagnostics — segment assets mean?
The total value of all assets dedicated to the Specialty Diagnostics business unit.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.